Real-world Efficacy of Direct-Acting Antiviral Therapy for HCV Infection Affecting People Who Inject Drugs Delivered in a Multidisciplinary Setting

A VIDC study evaluating real-world direct-acting antiviral treatment outcomes among people who inject drugs within a multidisciplinary model of care.

Publication Details

Authors Arshia Alimohammadi, Julie Holeksa, Astou Thiam, David Truong, Brian Conway

Published In / Presented At Open Forum Infectious Diseases

DOI / Reference 10.1093/ofid/ofy120

View Source

View the original publication.

Access the full paper, conference material or external publication source where available.

View Original Source

Research at VIDC

Discovery connected to care.

Explore current studies, research participation and the broader areas of research underway at VIDC.

Explore Research

Explore Current Studies Learn About Research Participation Browse All Published Work

Continue Exploring

Related Published Work.

View All Published Work

Sep 2026

Barriers to Hepatitis B Treatment: A Multicentre Cross-Sectional Registry and Survey Study by the Canadian Hepatitis B Network.

BACKGROUND & AIMS: Chronic hepatitis B (CHB) remains a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, yet treatment uptake is…

View Publication

Jul 2026

Worldwide Impact of ACIP’s 2025 Overhaul.

View Publication

May 2026

Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis.

INTRODUCTION: Glecaprevir/pibrentasvir (G/P) is globally approved for the treatment of chronic hepatitis C virus (HCV) infection and for acute HCV infection in the…

View Publication

VIDC Research

Explore current research opportunities.

View Current Studies